Risk factors for linezolid-associated thrombocytopenia and negative effect of carbapenem combination

Creative Commons License

Kilic E. K., Bulut C., SÖNMEZER M. Ç., Ozel O., Hatipoglu C. A., Ertem G. T., ...Daha Fazla

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, cilt.13, sa.10, ss.886-891, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 13 Sayı: 10
  • Basım Tarihi: 2019
  • Doi Numarası: 10.3855/jidc.10859
  • Dergi Adı: JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.886-891
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Introduction: Linezolid is a synthetic antimicrobial agent with a broad spectrum of activity against virtually all Gram-positive bacteria. Although linezolid is generally well tolerated, the prolonged use of linezolid can lead to myelosuppression, including neutropenia, thrombocytopenia, and anemia. The aim of this study was investigating the risk factors for thrombocytopenia in patients who received linezolid therapy.